HIF-1α triggers long-lasting glutamate excitotoxicity via system x_c⁻in cerebral ischaemia-reperfusion

Abstract

Hypoxia-inducible factor 1α (HIF-1α) controls many genes involved in physiological and pathological processes. However, its roles in glutamatergic transmission and excitotoxicity are unclear. Here, we proposed that HIF-1α might contribute to glutamate-mediated excitotoxicity during cerebral ischaemia-reperfusion (CIR) and investigated its molecular mechanism. We showed that an HIF-1α conditional knockout mouse displayed an inhibition in CIR-induced elevation of extracellular glutamate and N-methyl-d-aspartate receptor (NMDAR) activation. By gene screening for glutamate transporters in cortical cells, we found that HIF-1α mainly regulates the cystine-glutamate transporter (system x ) subunit xCT by directly binding to its promoter; xCT and its function are up-regulated in the ischaemic brains of rodents and humans, and the effects lasted for several days. Genetic deletion of xCT in cortical cells of mice inhibits either oxygen glucose deprivation/reoxygenation (OGDR) or CIR-mediated glutamate excitotoxicity in vitro and in vivo. Pharmaceutical inhibition of system x by a clinically approved anti-cancer drug, sorafenib, improves infarct volume and functional outcome in rodents with CIR and its therapeutic window is at least 3 days. Taken together, these findings reveal that HIF-1α plays a role in CIR-induced glutamate excitotoxicity via the long-lasting activation of system x -dependent glutamate outflow and suggest that system x is a promising therapeutic target with an extended therapeutic window in stroke. Copyright © 2016 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

RGS4 deficit in prefrontal cortex contributes to the behaviors related to schizophrenia via system xc--mediated glutamatergic dysfunction in mice

“…Therefore, this PET radiotracer can be used for non-invasive observation of NMDAR activation in vivo . The results derived from our previous study showed the radioligand specificity of our synthesized 18 F-FSAG for the visualisation of NMDAR activation in vitro and in vivo using MK801 competition assay 53 . Here, our imaging data clearly showed that RGS4 deficit leads to NMDAR hypofunction in the prefrontal cortex, providing a better understanding of the complex nature of glutamate signaling in NMDAR-related disorders.…”

Mechanisms of Dexmedetomidine in Neuropathic Pain

“…Cerebral ischemia and hypoxia can lead to increased release of glutamate and aspartate (Hsieh et al, 2017). If the concentration of glutamic acid and aspartic acid in the extracellular fluid is increasing, an excessive concentration of the excitatory amino acid neurotransmitter glutamate causes N-methyl-D-aspartate receptor overactivation, which finally leads to neuronal cell apoptosis (Zhang et al, 2017).…”

Cross Talk Between Ferroptosis and Cerebral Ischemia

“…Excitotoxicity induced by xCT through glutamate receptors circumvents the antioxidant protection afforded by system xc-itself (Lewerenz et al, 2013). After the in vitro oxygen-glucose deprivation of neurons, HIF-1α binds to the promoter of xCT, upregulating its expression and then inducing injury (Hsieh et al, 2017). Conversely, the downregulation of xCT expression by N-acetylcysteine and ceftriaxone significantly reduced IS injury (Krzyżanowska et al, 2017).…”